1. 1556. Infectious Disease Complications with Use of Checkpoint Inhibitors in Solid Organ Malignancies. (26th November 2018) Authors: Komoda, Kellie; Ross, Justine Abella; Margolin, Kim; Pal, Sumanta; Dickter, Jana; Ito, James; Salgia, Ravi; Dadwal, Sanjeet Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2′‐Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76. Issue 12 (19th September 2018) Authors: Singhal, Jyotsana; Chikara, Shireen; Horne, David; Salgia, Ravi; Awasthi, Sanjay; Singhal, Sharad S. Journal: Molecular carcinogenesis Issue: Volume 57:Issue 12(2018) Page Start: 1751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 359 AMG 757, a half-life extended bispecific T-cell engager (BiTE®) immune therapy against DLL3 in SCLC: phase 1 interim results. (9th November 2020) Authors: Borghaei, Hossein; Boyer, Michael; Johnson, Melissa; Govindan, Ramaswamy; Rodrigues, Luis Paz-Ares; Blackhall, Fiona; Boosman, Rene; Champiat, Stéphane; Hummel, Horst-Dieter; Victoria Lai, W; Udagawa, Hibiki; Chiang, Anne; Dowlati, Afshin; Hann, Christine; Salgia, Ravi; Vokes, Everett; Minocha, M... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 359 AMG 757, a half-life extended bispecific T-cell engager (BiTE®) immune therapy against DLL3 in SCLC: phase 1 interim results. (9th November 2020) Authors: Borghaei, Hossein; Boyer, Michael; Johnson, Melissa; Govindan, Ramaswamy; Rodrigues, Luis Paz-Ares; Blackhall, Fiona; Boosman, Rene; Champiat, Stéphane; Hummel, Horst-Dieter; Victoria Lai, W; Udagawa, Hibiki; Chiang, Anne; Dowlati, Afshin; Hann, Christine; Salgia, Ravi; Vokes, Everett; Minocha, M... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A new PET/CT volumetric prognostic index for non-small cell lung cancer. Issue 1 (July 2015) Authors: Zhang, Hao; Wroblewski, Kristen; Jiang, Yulei; Penney, Bill C.; Appelbaum, Daniel; Simon, Cassie A.; Salgia, Ravi; Pu, Yonglin Journal: Lung cancer Issue: Volume 89:Issue 1(2015:Jul.) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive‐disease small cell lung cancer. (March 2017) Authors: Salgia, Ravi; Stille, John R.; Weaver, R. Waide; McCleod, Michael; Hamid, Oday; Polzer, John; Roberson, Stephanie; Flynt, Amy; Spigel, David R. Journal: Lung cancer Issue: Volume 105(2017) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients. (March 2015) Authors: Dikopf, Alana; Wood, Kevin; Salgia, Ravi Journal: Expert opinion on drug safety Issue: Volume 14:Number 3(2015:May) Page Start: 485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial. Issue 12 (December 2016) Authors: Gettinger, Scott N; Bazhenova, Lyudmila A; Langer, Corey J; Salgia, Ravi; Gold, Kathryn A; Rosell, Rafael; Shaw, Alice T; Weiss, Glen J; Tugnait, Meera; Narasimhan, Narayana I; Dorer, David J; Kerstein, David; Rivera, Victor M; Clackson, Timothy; Haluska, Frank G; Camidge, David Ross Journal: Lancet oncology Issue: Volume 17:Issue 12(2016:Dec.) Page Start: 1683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Adaptive Therapy As Novel Treatment Strategy in Medical Oncology. Issue 17 (5th September 2022) Authors: Mittan, Sandeep; Kulkarni, Prakash; Salgia, Ravi Journal: Oncology times Issue: Volume 44:Issue 17(2022) Page Start: 1, 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. ALK-Directed Therapy in Non-NSCLC Malignancies: Are We Ready?. (2021) Authors: Salgia, Sabrina K.; Govindarajan, Ameish; Salgia, Ravi; Pal, Sumanta K. Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗